Francesca Buontempo

Bologna, 40126, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Diet Modulation Restores Autophagic Flux in Damaged Skeletal Muscle Cells.

Diet Modulation Restores Autophagic Flux in Damaged Skeletal Muscle Cells.

Journal: The journal of nutrition, health & aging
Published: September 28, 2019

Drug discovery targeting the mTOR pathway.

Drug discovery targeting the mTOR pathway.

Journal: Clinical science (London, England : 1979)
Published: January 22, 2018

Marine bisindole alkaloid: A potential apoptotic inducer in human cancer cells.

Marine bisindole alkaloid: A potential apoptotic inducer in human cancer cells.

Journal: European journal of histochemistry : EJH
Published: December 12, 2017

Therapeutic targeting of CK2 in acute and chronic leukemias.

Therapeutic targeting of CK2 in acute and chronic leukemias.

Journal: Leukemia
Published: July 20, 2017

Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device.

Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device.

Journal: PloS one
Published: June 22, 2017

Protective effect of different antioxidant agents in UVB-irradiated keratinocytes.

Protective effect of different antioxidant agents in UVB-irradiated keratinocytes.

Journal: European journal of histochemistry : EJH
Published: March 08, 2017

Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.

Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.

Journal: Journal of cellular physiology
Published: March 03, 2017

Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.

Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.

Journal: Journal of hematology & oncology
Published: July 12, 2016

Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.

Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.

Journal: Leukemia
Published: May 26, 2016

Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells.

Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells.

Journal: Histology and histopathology
Published: August 09, 2015

Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.

Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.

Journal: Oncotarget
Published: June 19, 2015

Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.

Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.

Journal: Biochimica et biophysica acta
Published: May 25, 2015
Showing 1-12 of 26

Last Updated: 09/26/2026